State Street Corp Vericel Corp Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Vericel Corp stock. As of the latest transaction made, State Street Corp holds 2,404,711 shares of VCEL stock, worth $131 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,404,711

Previous 2,429,558 1.02%

Holding current value

$131 Million

Previous $103 Million 28.64%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$40.05 - $59.11 $995,122 - $1.47 Million	-24,847 Reduced 1.02%	2,404,711 $132 Million
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $2.33 Million - $2.96 Million	-55,227 Reduced 2.22%	2,429,558 $103 Million
Q2 2024 Aug 14, 2024	SELL	$41.71 - $52.9 $30.4 Million - $38.6 Million	-729,883 Reduced 22.7%	2,484,785 $114 Million
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $17.9 Million - $28.8 Million	549,785 Added 20.63%	3,214,668 $167 Million
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $887,863 - $1.07 Million	-28,780 Reduced 1.07%	2,664,883 $94.9 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $6.62 Million - $8.2 Million	208,823 Added 8.4%	2,693,663 $90.3 Million
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $7.07 Million - $9.36 Million	-243,953 Reduced 8.94%	2,484,840 $93.4 Million
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $15.2 Million - $19.9 Million	-635,410 Reduced 18.89%	2,728,793 $80 Million
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $4.83 Million - $7.48 Million	273,467 Added 8.85%	3,364,203 $88.6 Million
Q3 2022 Nov 15, 2022	SELL	$22.62 - $32.54 $7.01 Million - $10.1 Million	-309,999 Reduced 9.12%	3,090,736 $71.7 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $10.5 Million - $18.1 Million	458,219 Added 15.57%	3,400,735 $85.6 Million
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $4.21 Million - $5.75 Million	132,856 Added 4.73%	2,942,516 $112 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $10.8 Million - $16.2 Million	307,755 Added 12.3%	2,809,660 $110 Million
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $13.5 Million - $17.5 Million	292,219 Added 13.22%	2,501,905 $122 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $10.4 Million - $14.9 Million	-220,293 Reduced 9.07%	2,209,686 $116 Million
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $7.54 Million - $14.5 Million	243,760 Added 11.15%	2,429,979 $135 Million
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $2.97 Million - $5.06 Million	160,532 Added 7.92%	2,186,219 $67.5 Million
Q3 2020 Nov 10, 2020	SELL	$14.68 - $19.12 $12.3 Million - $16 Million	-839,410 Reduced 29.3%	2,025,687 $37.5 Million
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $9.23 Million - $17.2 Million	1,085,912 Added 61.03%	2,865,097 $39.6 Million
Q1 2020 May 11, 2020	BUY	$7.25 - $19.22 $12.9 Million - $34.2 Million	1,779,185 New	1,779,185 $16.3 Million

Others Institutions Holding VCEL

# of Institutions

291

Shares Held

50.7M

Call Options Held

98.2K

Put Options Held

135K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.56B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Vericel Corp Transaction History